Latest Articles
Step Pharma secures €2.5 million EIC grant to accelerate development of dencatistat for CTPS2 null gynaecological tumours - The Manila Times
Step Pharma secures €2.5 million EIC grant to accelerate development of dencatistat for CTPS2 null gynaecological tumours The Manila Times
Published: Feb. 19, 2026, 12:12 p.m.
‘I thought I had endometriosis – then I got my stage 4 cancer diagnosis’ - The Independent
‘I thought I had endometriosis – then I got my stage 4 cancer diagnosis’ The Independent
Published: Feb. 19, 2026, 12:03 p.m.
Endometriosis and PMDD public meeting to be held in Ballymun on Thursday evening - The Irish Independent
Endometriosis and PMDD public meeting to be held in Ballymun on Thursday evening The Irish Independent
Published: Feb. 19, 2026, 9:49 a.m.
Gaudium IVF and Women Health ipo date, Share Price Target Tomorrow, 2026, 2027, 2030 - shareprice-target.com
Gaudium IVF and Women Health ipo date, Share Price Target Tomorrow, 2026, 2027, 2030 shareprice-target.com
Published: Feb. 19, 2026, 8:30 a.m.
Aprea reports second partial response in endometrial cancer trial By Investing.com - Investing.com South Africa
Aprea reports second partial response in endometrial cancer trial By Investing.com Investing.com South Africa
Published: Feb. 19, 2026, 12:54 a.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com Nigeria
Aprea reports second partial response in endometrial cancer trial Investing.com Nigeria
Published: Feb. 18, 2026, 11:46 p.m.
Get up to 42% off a Max annual subscription when you prepay for one year - Mashable
Get up to 42% off a Max annual subscription when you prepay for one year Mashable
Published: Feb. 18, 2026, 11 p.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com
Aprea reports second partial response in endometrial cancer trial Investing.com
Published: Feb. 18, 2026, 1:42 p.m.
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - European Medical Journal
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk European Medical Journal
Published: Feb. 18, 2026, noon
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally
Published: Feb. 18, 2026, noon
Link copied to clipboard!